Tempus AI, Inc. (NASDAQ:TEM) COO Ryan Fukushima Sells 3,500 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) COO Ryan Fukushima sold 3,500 shares of Tempus AI stock in a transaction on Monday, December 16th. The stock was sold at an average price of $40.23, for a total value of $140,805.00. Following the transaction, the chief operating officer now owns 1,003,707 shares in the company, valued at approximately $40,379,132.61. This represents a 0.35 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Ryan Fukushima also recently made the following trade(s):

• On Wednesday, December 11th, Ryan Fukushima sold 120,000 shares of Tempus AI stock. The stock was sold at an average price of $42.51, for a total transaction of $5,101,200.00.

Tempus AI Price Performance

TEM opened at $33.03 on Friday. The business’s 50-day moving average price is $51.96. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $79.49. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Institutional Trading of Tempus AI

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Kovitz Investment Group Partners LLC acquired a new stake in shares of Tempus AI in the third quarter valued at $1,367,000. Sumitomo Mitsui Trust Group Inc. increased its holdings in Tempus AI by 1,591.2% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock worth $68,922,000 after purchasing an additional 1,145,698 shares during the period. Captrust Financial Advisors purchased a new stake in Tempus AI during the 3rd quarter worth about $2,726,000. Sigma Planning Corp acquired a new stake in Tempus AI in the 3rd quarter valued at about $1,323,000. Finally, Dakota Wealth Management purchased a new position in shares of Tempus AI in the 3rd quarter valued at about $1,185,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on TEM shares. Guggenheim began coverage on shares of Tempus AI in a report on Monday, December 9th. They issued a “buy” rating and a $74.00 target price on the stock. Piper Sandler reiterated a “neutral” rating and issued a $70.00 price objective (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Wolfe Research started coverage on Tempus AI in a research note on Friday, December 13th. They set an “outperform” rating and a $60.00 target price for the company. Bank of America upped their price target on Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research note on Friday, December 13th. Finally, Loop Capital raised their price objective on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $56.00.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.